Q: What exactly does the PRELI test measure?
Xambika’s PRELI test measures the decidual reaction, a key, time-sensitive process that first prepares the endometrium for embryo implantation and then supports placental development. The test identifies whether the response is normal, stalled, or accelerated. An accelerated decidual reaction increases the risk of implantation failure. Stalling of this process renders the womb lining vulnerable to breaking down in pregnancy, causing miscarriage. In addition, the test also looks at molecular timing, immune readiness, and infection.
Q: How does the PRELI test differ from other tests?
While most existing fertility tests each look at a single component of the endometrium (timing, microbiome, or immune activity) none of them measure the process that matters most. Xambika’s PRELI is the only test that accurately measures the dynamic decidual reaction, the critical inflammatory transformation that allows embryos to implant and pregnancies to progress. Combined with insights on molecular timing, immune readiness, and infection, the test delivers a uniquely comprehensive view that supports precise, personalised intervention.
Q: What clinical questions can the PRELI test answer for my patients?
The PRELI test helps distinguish whether reproductive failure is likely driven by the endometrium, or not. It guides decisions on pre-conception interventions and next steps, reducing trial-and-error approaches.
Q: For whom is the PRELI test most appropriate?
Xambika’s PRELI test is intended for patients who experienced miscarriage, implantation failure, or suspected endometrial timing, immune, or infection issues.
Q: The endometrial lining changes each cycle. How stable is the decidual reaction across menstrual cycles?
Abnormal decidual responses (weakened or excessive) recur across cycles far more frequently than by chance alone, enabling reliable risk identification and pre-pregnancy intervention.
Q: What actionable insights does the PRELI test provide?
Xambika’s PRELI test is the only diagnostic test that evaluates the decidual reaction, the central biological process that prepares the womb lining for implantation and pregnancy progression. Instead of providing raw data, we deliver a personalised report that outlines your patient’s profile and offers evidence-based recommendations for pre-conception care. This helps you make informed decisions about the most appropriate clinical pathway. If you have questions or wish to discuss a specific result, you also have direct access to a Xambika doctor, ensuring expert support is available whenever needed.
Q: What is the best time to take the biopsy?
A standard endometrial biopsy is taken 6-10 days after a positive ovulation test (peak day) in a natural cycle or a modified natural cycle with progesterone support, or 6-10 days after starting progesterone in an artificial/medicated cycle.
Q: What technology underpins the PRELI test?
The core platform uses digital droplet PCR (ddPCR), enabling highly sensitive and quantitative analysis of multiple molecular markers involved in decidualisation, immune readiness, and infection.
Q: Can the PRELI test be used before IVF cycles or natural conception?
Xambika’s PRELI test is specifically designed for pre-pregnancy evaluation, allowing targeted interventions before attempts at conception, whether through IVF or natural conception.
Q: What evidence supports Xambika’s PRELI test?
Xambika’s PRELI test is built on 20 years of research, including the world’s largest study of its kind (1,500+ biopsies), published in Science Advances, showing abnormal decidualisation as a preventable cause of miscarriage and implantation failure.
Q: When should the PRELI test be repeated?
The womb lining is a dynamic tissue that can change over time. Your doctor may advise repeating the PRELI test in case of further failure. In addition, your doctor may also wish to repeat the PRELI test to examine the response of your womb lining to personalised treatment prior to embryo transfer or pregnancy.
Q: Does the PRELI test delay IVF cycles?
Not typically. Results can guide optimisation of the womb lining in the next cycle.
Q: How do I integrate Xambika’s PRELI test into my clinical workflow?
You can order the PRELI test kit, take a biopsy and have it picked up by our logistics partner, who will transport it to the Xambika lab in the designated packaging. You will receive a structured results report, clear interpretation guidance, and access to clinical experts for case discussion if desired. We equip you with the clarity and confidence to explain the findings and discuss the next personalised steps with your patient.
Q: Can the PRELI test guide timing of embryo transfer?
There is currently no robust evidence that adjusting the timing of embryo transfer improves outcomes. Instead of focusing on timing alone, Xambika’s PRELI test assesses whether the endometrium is biologically permissive for implantation and adequately prepared to transform into early pregnancy tissue.
Q: Alongside the PRELI test, do I need to perform other assessment?
Yes. We ask clinicians to collect a serum progesterone sample on the same day as the endometrial biopsy. Although we do not perform the blood analysis ourselves, we require the progesterone result in order to release the comprehensive report. This value is essential for interpretation, as it helps determine whether an abnormal endometrial profile is influenced by progesterone levels that are outside the expected physiological range for that cycle day, or whether it reflects intrinsic endometrial dysfunction.
Q: What happens after sample collection?
Once the biopsy is taken, our logistics partner collects it and transports it directly to the Xambika laboratory, where it is processed and analysed. Each test kit includes clear instructions to guide clinics through each step of the collection and handover process.
